Skip to main content
. 2021 Sep 2;13(4):424–430. doi: 10.4103/UA.UA_139_20

Table 2.

Grading of adverse effects in adjuvant Hyperthermic Intra VEsical Chemotherapy with mitomycin group and intravesical Bacillus Calmette-Guerin (Moscow I strain) group

Adverse effects HIVEC n (%) BCG n (%) P
Nil 19 (86.4) 4 (13.8) 0.001
Grade I 2 (9.1) 6 (20.7) 0.331
Grade II 0 (0) 13 (44.8) Significant
Grade III 1 (4.5) 6 (20.7) 0.143

HIVEC: Hyperthermic Intra-VEsical Chemotherapy, BCG: Bacillus Calmette-Guerin